Zelenetz A - Search Results

1

The radioisotope contributes significantly to the activity of radioimmunotherapy.

Davis TA, Kaminski MS, Leonard JP, Hsu FJ, Wilkinson M, Zelenetz A, Wahl RL, Kroll S, Coleman M, Goris M, Levy R, Knox SJ. Davis TA, et al. Among authors: zelenetz a. Clin Cancer Res. 2004 Dec 1;10(23):7792-8. doi: 10.1158/1078-0432.CCR-04-0756. Clin Cancer Res. 2004. PMID: 15585610 Clinical Trial.

2

Antigen selection in human lymphomagenesis.

Bahler DW, Zelenetz AD, Chen TT, Levy R. Bahler DW, et al. Among authors: zelenetz ad. Cancer Res. 1992 Oct 1;52(19 Suppl):5547s-5551s. Cancer Res. 1992. PMID: 1394171 Review.

3

Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire.

Campbell MJ, Zelenetz AD, Levy S, Levy R. Campbell MJ, et al. Among authors: zelenetz ad. Mol Immunol. 1992 Feb;29(2):193-203. doi: 10.1016/0161-5890(92)90100-c. Mol Immunol. 1992. PMID: 1542297

4

Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy.

Kwak LW, Campbell MJ, Zelenetz AD, Levy R. Kwak LW, et al. Among authors: zelenetz ad. Blood. 1991 Nov 15;78(10):2768-72. Blood. 1991. PMID: 1824269 Free article.

5

Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis.

Zelenetz AD, Chu G, Galili N, Bangs CD, Horning SJ, Donlon TA, Cleary ML, Levy R. Zelenetz AD, et al. Blood. 1991 Sep 15;78(6):1552-60. Blood. 1991. PMID: 1884022 Free article.

6

Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell.

Zelenetz AD, Chen TT, Levy R. Zelenetz AD, et al. J Exp Med. 1991 Jan 1;173(1):197-207. doi: 10.1084/jem.173.1.197. J Exp Med. 1991. PMID: 1898660 Free PMC article.

7

Directional cloning of cDNA using a selectable SfiI cassette.

Zelenetz AD, Levy R. Zelenetz AD, et al. Gene. 1990 Apr 30;89(1):123-7. doi: 10.1016/0378-1119(90)90214-c. Gene. 1990. PMID: 2165017

8

Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin.

Kwak LW, Campbell MJ, Zelenetz AD, Levy R. Kwak LW, et al. Among authors: zelenetz ad. Blood. 1990 Dec 1;76(11):2411-7. Blood. 1990. PMID: 2257310 Free article.

9

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.

Vose JM, Wahl RL, Saleh M, Rohatiner AZ, Knox SJ, Radford JA, Zelenetz AD, Tidmarsh GF, Stagg RJ, Kaminski MS. Vose JM, et al. Among authors: zelenetz ad. J Clin Oncol. 2000 Mar;18(6):1316-23. doi: 10.1200/JCO.2000.18.6.1316. J Clin Oncol. 2000. PMID: 10715303 Clinical Trial.

10

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

Kaminski MS, Zelenetz AD, Press OW, Saleh M, Leonard J, Fehrenbacher L, Lister TA, Stagg RJ, Tidmarsh GF, Kroll S, Wahl RL, Knox SJ, Vose JM. Kaminski MS, et al. Among authors: zelenetz ad. J Clin Oncol. 2001 Oct 1;19(19):3918-28. doi: 10.1200/JCO.2001.19.19.3918. J Clin Oncol. 2001. PMID: 11579112 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters